BODI Earnings

BODI reported its FY2025Q3 earnings on 2025-11-10, showcasing a revenue of 59.89M against an estimate of 54.80M, resulting in a 9.28% surprise. The EPS was 0.51, surpassing the expected -0.54 by 194.44% . The stock experienced a 17.93% price change on the earnings day and a 24.9% change over the next five days, reflecting market reactions to the results.

Following BODI's FY2025Q3 earnings announcement on 2025-11-10, the stock price moved by 17.93% on the day of the release. Over the subsequent five days, it saw a 24.90% change. Historically, BODI's stock price tends to shift by an average of -2.79% in the 10 days leading up to earnings and +1.62% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate BODI’s annual revenue to reach 54.23M, while the EPS is projected at -0.01. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 2.35% and EPS estimates Revise Upward by 1.84% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between BODI's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 2.35%, while EPS estimates moved Revise Upward by 1.84% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, BODI's stock price typically moves by -2.79% in the 10 days before its earnings and +1.62% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -0.01 and revenue of 54.23M.

The company's strategic shift from MLM to an omnichannel model led to a significant revenue decline, but improved gross margins and reduced operating expenses. The positive cash position and reduced revenue breakeven point are encouraging, yet the unclear guidance on marketing spend and the decline in digital and nutrition revenues raise concerns. The Q&A session highlighted ongoing product launches and retail expansion plans, but management's vague responses on key details tempered optimism. Overall, the sentiment is neutral, reflecting mixed signals from financial performance and future growth prospects.